Overview
Pioligon provides discovery services for peptides containing nonstandard amino acids. It designs peptide drug candidates with the VPDesigner42™ algorithm, synthesizes selected molecules and measures their affinity.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 91 days late).
- 202515/07/2026
- 202431/01/2025
- 202315/07/2024
- 202215/07/2023
- 202114/10/2022
- 202015/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Offer
- Computational peptide design
- Peptide synthesis
- Affinity measurements
- Binding validation
- Peptide drug candidate discovery
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Filip Liguzińskiage 47 | 20 | $270.12 | 20% |
Piotr Liguzińskiage 45 | 80 | $1,080.50 | 80% |
Piotr Liguziński and Filip Liguziński hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-07-01.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $329,599.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 26, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $18,750$18,750 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Apr 22, 2021 | Aid for SME access to finance — aid for start-ups | $258.7K$258,739 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| May 21, 2020 | Aid for SME access to finance — aid for start-ups | $45,109$45,109 | Fundacja Przedsiębiorczości Technologicznej |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-09-04 | Preparation of an application to the EIC Pre-Accelerator programme by PioLigOn Sp. z o.o. | $17,431$17,431 | European Funds for a Modern Economy | |
| 2021-05-01 | PioLigOn – design of peptide drugs and diagnostic peptides. | $258.7K$258,739 | Operational Programme Eastern Poland |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MultiqureS.A. | $284,781.52 | purebiologics.com | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Sfpesp. z o.o. | $72,850.26 | sfpe.co.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Receptonsp. z o.o. | $50,611.05 | receptonbiotech.com | ||
| ETA Innovations Research Hub Not for Profitsp. z o.o. | $49,920.43 | etainnovations.com | ||
| Orphinic ScientificS.A. | $42,972.42 | orphinic.com | ||
| NanovelosS.A. | $24,842.03 | nanovelos.com | ||
| Fusiomicasp. z o.o. | $5,263.98 | fusiomica.com |
FAQ
Last updated: 2026-07-17